Alnylam sues Moderna and Pfizer over key vaccine ingredient
March 23, 2022Research and Development
Alnylam Pharmaceuticals, a Cambridge, Massachusetts-based company, has sued Moderna and Pfizer over allegations that the firms used patented nanoparticle technology …
ONS says no evidence that COVID-19 vaccines lead to young deaths
March 23, 2022Research and Development
The Office for National Statistics (ONS) has said that there is no evidence that COVID-19 vaccines have led to an …
Pfizer to supply UNICEF oral COVID-19 treatment for low- and middle-income countries
March 23, 2022Research and Development
Pfizer have announced the signing of a supply agreement with the United Nations Children’s Fund (UNICEF), to deliver up to …
FDA approval for first drug for rare form of epilepsy
March 22, 2022Manufacturing and Production
Those living in the US with CDKL5 deficiency disorder, or CDD, may now have access to the first FDA-approved treatment …
MDMA improves PTSD symptoms, study finds
March 22, 2022Manufacturing and Production
In findings presented at the American Chemical Society’s (ACS) Spring Meeting for 2022, researchers reported on follow-up results form a …
Pfizer recalls blood pressure drug due to potential carcinogen
March 22, 2022Manufacturing and Production
Pfizer is voluntarily recalling certain hypertension medications due to the potential presence of impurities. The affected products have been distributed …
Collaboration to offer heart rhythm checks to detect atrial fibrillation
March 22, 2022Manufacturing and Production
Daiichi Sankyo and O’Brien’s Pharmacies Group have today announced the launch of a collaboration in North West England to offer …
Ipsen appoints Guy Oliver as General Manager, UK & Ireland
March 21, 2022Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …
FDA approval for first in class immunotherapy for advanced melanoma
March 21, 2022Sales and Marketing
The FDA has approved Bristol-Myers Squibb’s Opdualag (nivolumab and relatlimab-rmbw), the first drug in a new class of cancer immunotherapies, …
Spring COVID-19 booster launches for over-75s and high risk in England
March 21, 2022Sales and Marketing
Those aged 75 and over, alongside residents in care homes and those with weakened immune systems, can now book an …
UCLA’s HIV prevention and treatment centre receives $7.5 million NIH grant
March 21, 2022Sales and Marketing
The National Institute of Mental Health has renewed its support for UCLA’s collaborative Centre for HIV Identification, Prevention and Treatment …
Merck’s Keytruda delivers reduced risk of death in adjuvant NSCLC
March 21, 2022Sales and Marketing
Merck has announced positive results from its Phase III trial into Keytruda for non-small cell lung cancer. The KEYNOTE-091 study …
Moderna seeks FDA authorisation for fourth COVID-19 jab for adults
March 18, 2022Medical Communications
Moderna has requested an EUA from the FDA for a fourth dose of its COVID-19 vaccine, as a booster for …
NIH fund research for Short Bowel Syndrome
March 18, 2022Medical Communications
A Saint Louis University School of Medicine physician-scientist has received funding of $428,020, from the National Institutes of Allergy and …
GSK halts new clinical trials in Russia
March 18, 2022Medical Communications
Britain’s second biggest drugmaker, GlaxoSmithKline (GSK), has joined other pharmaceutical companies including Pfizer, sharing that it will not start clinical …
AstraZeneca could abandon US regulatory efforts for COVID-19 vaccine
March 18, 2022Medical Communications
The Oxford/AstraZeneca vaccine has not yet been approved in the US, and has not been submitted for Emergency Use Authorisation …
Global COVID-19 cases up for first time in weeks
March 17, 2022Business Services
After more than a month of decline, global cases of COVID-19 have increased. WHO have stated that cases of the …
War in Ukraine could worsen COVID-19 pandemic, says WHO
March 17, 2022Business Services
WHO has expressed concern that the war in Ukraine could worsen the COVID-19 pandemic, and it is aiming to do …
Ukraine: Health facilities a “target” of war
March 17, 2022Business Services
Healthcare facilities have become a “target” of war, WHO has said, warning that the health system in Ukraine is “teetering …
Targeted drug Olaparib improves survival in early-stage breast cancer
March 17, 2022Business Services
The Institute of Cancer Research (ICR), London, has reported new findings that the targeted drug olaparib improves survival in women …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
